{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:42:29Z","timestamp":1790797349808,"version":"4.1.0"},"reference-count":133,"publisher":"European Respiratory Society (ERS)","issue":"177","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2025,6,5]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Pulmonary fibrosis remains a devastating and often fatal condition due to the lack of effective treatments that halt disease progression. Rodent models of pulmonary fibrosis are crucial to identify candidate targets and novel therapeutic agents. However, the attrition rate of novel drug candidates in clinical trials remains high. This review suggests complementing traditional methods used to evaluate antifibrotic therapies in rodent models, such as histopathological and biochemical markers, and lung function tests, with innovative imaging technologies. These imaging techniques could improve the predictive power and translatability of animal studies in human clinical trials. Notably, previous studies in mice and other rodents have observed compensatory lung enlargement in response to lung injury, questioning whether the conventional view of pulmonary fibrosis as a restrictive disease applies to rodents. By adding longitudinal image-based biomarkers, we aim to better unravel the complexity of lung responses and facilitate more effective drug development for pulmonary fibrosis, ultimately improving patient outcomes.<\/jats:p>","DOI":"10.1183\/16000617.0012-2025","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T08:50:32Z","timestamp":1756889432000},"page":"250012","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Imaging technologies in experimental pulmonary fibrosis research: essential tool for enhanced translational relevance"],"prefix":"10.1183","volume":"34","author":[{"given":"Flore","family":"Belmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5959-3777","authenticated-orcid":false,"given":"Irma","family":"Mahmutovic Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8565-0293","authenticated-orcid":false,"given":"Sam","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Eaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8054-2293","authenticated-orcid":false,"given":"Joseph","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1370-9417","authenticated-orcid":false,"given":"Rachel C.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greetje","family":"Vande Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"2025090301501398000_34.177.250012.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705751"},{"key":"2025090301501398000_34.177.250012.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0021-2019"},{"key":"2025090301501398000_34.177.250012.3","doi-asserted-by":"crossref","first-page":"101227","DOI":"10.1016\/j.mam.2023.101227","article-title":"Pulmonary fibrosis: emerging diagnostic and therapeutic strategies","volume":"94","author":"Selvarajah","year":"2023","journal-title":"Mol Aspects Med"},{"key":"2025090301501398000_34.177.250012.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"2025090301501398000_34.177.250012.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2025090301501398000_34.177.250012.6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01950-0"},{"key":"2025090301501398000_34.177.250012.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01209-2017"},{"key":"2025090301501398000_34.177.250012.8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2208"},{"key":"2025090301501398000_34.177.250012.9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial","volume":"5","author":"Raghu","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2025090301501398000_34.177.250012.10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2213-2600(16)30420-9","article-title":"Great expectations for simtuzumab in IPF fall short","volume":"5","author":"Meyer","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2025090301501398000_34.177.250012.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200404-531OC"},{"key":"2025090301501398000_34.177.250012.12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419603"},{"key":"2025090301501398000_34.177.250012.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0964OC"},{"key":"2025090301501398000_34.177.250012.14","first-page":"P668","article-title":"Rapid reversal of radiation-induced murine pneumonitis by treatment with the anti-CTGF monoclonal antibody FG-3019","volume":"38","author":"Lipson","year":"2011","journal-title":"Eur Respir J"},{"key":"2025090301501398000_34.177.250012.15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2024.8693","article-title":"Pamrevlumab for idiopathic pulmonary fibrosis: the ZEPHYRUS-1 randomized clinical trial","volume":"332","author":"Raghu","year":"2024","journal-title":"JAMA"},{"key":"2025090301501398000_34.177.250012.16","doi-asserted-by":"crossref","first-page":"1303646","DOI":"10.3389\/fphar.2023.1303646","article-title":"Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis","volume":"14","author":"Murgo","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025090301501398000_34.177.250012.17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2023"},{"key":"2025090301501398000_34.177.250012.18","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1038\/s41467-020-19449-7","article-title":"Deep learning-enabled multi-organ segmentation in whole-body mouse scans","volume":"11","author":"Schoppe","year":"2020","journal-title":"Nat Commun"},{"key":"2025090301501398000_34.177.250012.19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12931-022-02236-x","article-title":"A fully automated deep learning pipeline for micro-CT-imaging-based densitometry of lung fibrosis murine models","volume":"23","author":"Vincenzi","year":"2022","journal-title":"Respir Res"},{"key":"2025090301501398000_34.177.250012.20","doi-asserted-by":"crossref","first-page":"105712","DOI":"10.1016\/j.isci.2022.105712","article-title":"Automated segmentation of lungs and lung tumors in mouse micro-CT scans","volume":"25","author":"Ferl","year":"2022","journal-title":"iScience"},{"key":"2025090301501398000_34.177.250012.21","unstructured":"Eurostat . Healthcare resource statistics \u2013 technical resources and medical technology. Date last accessed: 9 January 2025. Date last updated: July 2024. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Healthcare_resource_statistics_-_technical_resources_and_medical_technology"},{"key":"2025090301501398000_34.177.250012.22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1754-9485.13125","article-title":"Radiology in the era of value-based healthcare: a multi-society expert statement from the ACR, CAR, ESR, IS3R, RANZCR and RSNA","volume":"65","author":"Brady","year":"2021","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2025090301501398000_34.177.250012.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00957-2022"},{"key":"2025090301501398000_34.177.250012.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2025090301501398000_34.177.250012.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2025090301501398000_34.177.250012.26","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0272-2022"},{"key":"2025090301501398000_34.177.250012.27","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1007\/s00330-021-07798-w","article-title":"Quantification of dual-energy CT-derived functional parameters as potential imaging markers for progression of idiopathic pulmonary fibrosis","volume":"31","author":"Scharm","year":"2021","journal-title":"Eur Radiol"},{"key":"2025090301501398000_34.177.250012.28","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ejrad.2016.06.024","article-title":"Value of ultra-low-dose chest CT with iterative reconstruction for selected emergency room patients with acute dyspnea","volume":"85","author":"Macri","year":"2016","journal-title":"Eur J Radiol"},{"key":"2025090301501398000_34.177.250012.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2020.12.041"},{"key":"2025090301501398000_34.177.250012.30","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13629"},{"key":"2025090301501398000_34.177.250012.31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.radi.2021.07.010","article-title":"The use of deep learning towards dose optimization in low-dose computed tomography: a scoping review","volume":"28","author":"Immonen","year":"2022","journal-title":"Radiography (Lond)"},{"key":"2025090301501398000_34.177.250012.32","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221257"},{"key":"2025090301501398000_34.177.250012.33","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41598-023-27627-y","article-title":"Deep 3D reconstruction of synchrotron X-ray computed tomography for intact lungs","volume":"13","author":"Shin","year":"2023","journal-title":"Sci Rep"},{"key":"2025090301501398000_34.177.250012.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2014.05.011"},{"key":"2025090301501398000_34.177.250012.35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.2020201138","article-title":"Expanding applications of pulmonary MRI in the clinical evaluation of lung disorders: Fleischner Society position paper","volume":"297","author":"Hatabu","year":"2020","journal-title":"Radiology"},{"key":"2025090301501398000_34.177.250012.36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejrad.2016.09.015","article-title":"The role of hyperpolarized 129xenon in MR imaging of pulmonary function","volume":"86","author":"Ebner","year":"2017","journal-title":"Eur J Radiol"},{"key":"2025090301501398000_34.177.250012.37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120485"},{"key":"2025090301501398000_34.177.250012.38","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.244780"},{"key":"2025090301501398000_34.177.250012.39","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0051-2016"},{"key":"2025090301501398000_34.177.250012.40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/0972-3919.202242","article-title":"FDG PET-CT: need for vigilance in patients treated with bleomycin","volume":"32","author":"Paschali","year":"2017","journal-title":"Indian J Nucl Med"},{"key":"2025090301501398000_34.177.250012.41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MNM.0000000000001299","article-title":"PET in the diagnostic management of infectious\/inflammatory pulmonary pathologies: a revisit in the era of COVID-19","volume":"42","author":"Katal","year":"2021","journal-title":"Nucl Med Commun"},{"key":"2025090301501398000_34.177.250012.42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-019-0974-5","article-title":"Absence of early metabolic response assessed by 18F-FDG PET\/CT after initiation of antifibrotic drugs in IPF patients","volume":"20","author":"Bondue","year":"2019","journal-title":"Respir Res"},{"key":"2025090301501398000_34.177.250012.43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12931-017-0556-3","article-title":"[18F]FDG PET\/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis","volume":"18","author":"Justet","year":"2017","journal-title":"Respir Res"},{"key":"2025090301501398000_34.177.250012.44","first-page":"623036","article-title":"The use of 18F-FDG-PET\/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases","volume":"2013","author":"Glaudemans","year":"2013","journal-title":"J Immunol Res"},{"key":"2025090301501398000_34.177.250012.45","first-page":"255","article-title":"An update on the role of 18F-FDG-PET\/CT in major infectious and inflammatory diseases","volume":"9","author":"Kung","year":"2019","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"2025090301501398000_34.177.250012.46","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201903-0503LE"},{"key":"2025090301501398000_34.177.250012.47","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.3390\/jcm9113706","article-title":"Longitudinal imaging using PET\/CT with collagen-I PET-tracer and MRI for assessment of fibrotic and inflammatory lesions in a rat lung injury model","volume":"9","author":"Mahmutovic Persson","year":"2020","journal-title":"J Clin Med"},{"key":"2025090301501398000_34.177.250012.48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf4696"},{"key":"2025090301501398000_34.177.250012.49","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.244723"},{"key":"2025090301501398000_34.177.250012.50","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1007\/s00259-022-05814-9","article-title":"[68Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity","volume":"49","author":"Rosenkrans","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025090301501398000_34.177.250012.51","doi-asserted-by":"crossref","first-page":"1306251","DOI":"10.3389\/fnume.2023.1306251","article-title":"Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tracer to assess inflammation and fibrogenesis in a reproducible lung injury rat model: a multimodal imaging study","volume":"3","author":"Boswinkel","year":"2023","journal-title":"Front Nucl Med"},{"key":"2025090301501398000_34.177.250012.52","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-462PP"},{"key":"2025090301501398000_34.177.250012.53","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(23)00325-9","article-title":"Idiopathic pulmonary fibrosis: aligning murine models to clinical trials in humans","volume":"11","author":"Chang","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2025090301501398000_34.177.250012.54","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202312-2213SO"},{"key":"2025090301501398000_34.177.250012.55","doi-asserted-by":"crossref","unstructured":"Spagnolo P , Cocconcelli E , Cottin V . Clinical trials in IPF: what are the best endpoints? In: Meyer KC , Nathan SD , eds. Idiopathic Pulmonary Fibrosis. Cham, Springer International Publishing, 2019; pp. 433\u2013453.","DOI":"10.1007\/978-3-319-99975-3_19"},{"key":"2025090301501398000_34.177.250012.56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1874306402014010022","article-title":"Effects of nintedanib on quantitative lung fibrosis score in idiopathic pulmonary fibrosis","volume":"14","author":"Lancaster","year":"2020","journal-title":"Open Respir Med J"},{"key":"2025090301501398000_34.177.250012.57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025090301501398000_34.177.250012.58","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial","volume":"6","author":"Maher","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2025090301501398000_34.177.250012.59","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208929"},{"key":"2025090301501398000_34.177.250012.60","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211779"},{"key":"2025090301501398000_34.177.250012.61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1513\/AnnalsATS.202211-915ST","article-title":"Quantitative imaging metrics for the assessment of pulmonary pathophysiology: an Official American Thoracic Society and Fleischner Society joint workshop report","volume":"20","author":"Hsia","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2025090301501398000_34.177.250012.62","doi-asserted-by":"crossref","unstructured":"Miller CG , Krasnow J , Schwartz LH , eds. Medical Imaging in Clinical Trials. London, Springer, 2014.","DOI":"10.1007\/978-1-84882-710-3"},{"key":"2025090301501398000_34.177.250012.63","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201803-0444PP"},{"key":"2025090301501398000_34.177.250012.64","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30286-8"},{"key":"2025090301501398000_34.177.250012.65","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S2213-2600(20)30003-5","article-title":"Imaging research in fibrotic lung disease; applying deep learning to unsolved problems","volume":"8","author":"Walsh","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025090301501398000_34.177.250012.66","unstructured":"US Food and Drug Administration . Letter of support. Date last accessed: 10 January 2025. Date last updated: 28 August 2024. www.fda.gov\/drugs\/biomarker-qualification-program\/letter-support-los"},{"key":"2025090301501398000_34.177.250012.67","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.rcl.2022.06.012","article-title":"Current imaging of idiopathic pulmonary fibrosis","volume":"60","author":"Gruden","year":"2022","journal-title":"Radiol Clin North Am"},{"key":"2025090301501398000_34.177.250012.68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S2213-2600(15)00096-X","article-title":"CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society","volume":"3","author":"Hansell","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2025090301501398000_34.177.250012.69","unstructured":"ClinicalTrials.gov . Nintedanib twice daily vs placebo in patients diagnosed with idiopathic pulmonary fibrosis (IPF). Date last accessed: 9 January 2025. Date last updated: 17 April 2018. https:\/\/clinicaltrials.gov\/study\/NCT01979952"},{"key":"2025090301501398000_34.177.250012.70","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes289"},{"key":"2025090301501398000_34.177.250012.71","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213865"},{"key":"2025090301501398000_34.177.250012.72","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.202312-2274LE","article-title":"e-Lung computed tomography biomarker stratifies patients at risk of idiopathic pulmonary fibrosis progression in a 52-week clinical trial","volume":"209","author":"Devaraj","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2025090301501398000_34.177.250012.73","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14333"},{"key":"2025090301501398000_34.177.250012.74","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/rccm.202311-2185OC","article-title":"Deep learning-based segmentation of computed tomography scans predicts disease progression and mortality in idiopathic pulmonary fibrosis","volume":"210","author":"Thillai","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2025090301501398000_34.177.250012.75","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1007\/s00330-023-09914-4","article-title":"Automated airway quantification associates with mortality in idiopathic pulmonary fibrosis","volume":"33","author":"Cheung","year":"2023","journal-title":"Eur Radiol"},{"key":"2025090301501398000_34.177.250012.76","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201711-2174OC"},{"key":"2025090301501398000_34.177.250012.77","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01011-2016"},{"key":"2025090301501398000_34.177.250012.78","doi-asserted-by":"crossref","first-page":"00637-2022","DOI":"10.1183\/23120541.00637-2022","article-title":"Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis","volume":"9","author":"Gudmundsson","year":"2023","journal-title":"ERJ Open Res"},{"key":"2025090301501398000_34.177.250012.79","doi-asserted-by":"crossref","first-page":"101009","DOI":"10.1016\/j.eclinm.2021.101009","article-title":"Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: survival analysis using visual and computer-based computed tomography assessment","volume":"38","author":"Gudmundsson","year":"2021","journal-title":"eClinicalMedicine"},{"key":"2025090301501398000_34.177.250012.80","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00313.2007"},{"key":"2025090301501398000_34.177.250012.81","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0096ST"},{"key":"2025090301501398000_34.177.250012.82","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2020-0542MA"},{"key":"2025090301501398000_34.177.250012.83","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.3390\/cells11213379","article-title":"A new model of acute exacerbation of experimental pulmonary fibrosis in mice","volume":"11","author":"Yegen","year":"2022","journal-title":"Cells"},{"key":"2025090301501398000_34.177.250012.84","doi-asserted-by":"publisher","DOI":"10.1113\/EP087322"},{"key":"2025090301501398000_34.177.250012.85","doi-asserted-by":"crossref","first-page":"1276420","DOI":"10.3389\/fmed.2024.1276420","article-title":"In vivo MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin","volume":"11","author":"Mahmutovic Persson","year":"2024","journal-title":"Front Med"},{"key":"2025090301501398000_34.177.250012.86","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00174914"},{"key":"2025090301501398000_34.177.250012.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.06.046"},{"key":"2025090301501398000_34.177.250012.88","doi-asserted-by":"crossref","first-page":"105347","DOI":"10.1016\/j.ebiom.2024.105347","article-title":"Damping excessive viral-induced IFN-\u03b3 rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis","volume":"108","author":"Seldeslachts","year":"2024","journal-title":"eBioMedicine"},{"key":"2025090301501398000_34.177.250012.89","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.4.467"},{"key":"2025090301501398000_34.177.250012.90","doi-asserted-by":"publisher","DOI":"10.2144\/000112729"},{"key":"2025090301501398000_34.177.250012.91","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-6-16"},{"key":"2025090301501398000_34.177.250012.92","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.23009"},{"key":"2025090301501398000_34.177.250012.93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063432"},{"key":"2025090301501398000_34.177.250012.94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","article-title":"Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis","volume":"809","author":"Egger","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2025090301501398000_34.177.250012.95","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00864-2021"},{"key":"2025090301501398000_34.177.250012.96","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.22476"},{"key":"2025090301501398000_34.177.250012.97","doi-asserted-by":"crossref","first-page":"16181","DOI":"10.1038\/s41598-020-73056-6","article-title":"Longitudinal micro-computed tomography-derived biomarkers quantify non-resolving lung fibrosis in a silicosis mouse model","volume":"10","author":"Dekoster","year":"2020","journal-title":"Sci Rep"},{"key":"2025090301501398000_34.177.250012.98","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40248-017-0089-0","article-title":"Longitudinal assessment of bleomycin-induced lung fibrosis by micro-CT correlates with histological evaluation in mice","volume":"12","author":"Ruscitti","year":"2017","journal-title":"Multidiscip Respir Med"},{"key":"2025090301501398000_34.177.250012.99","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00027.2014"},{"key":"2025090301501398000_34.177.250012.100","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000000071"},{"key":"2025090301501398000_34.177.250012.101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53876-x"},{"key":"2025090301501398000_34.177.250012.102","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.020321"},{"key":"2025090301501398000_34.177.250012.103","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fphys.2020.00584","article-title":"Imaging biomarkers and pathobiological profiling in a rat model of drug-induced interstitial lung disease induced by bleomycin","volume":"11","author":"Mahmutovic Persson","year":"2020","journal-title":"Front Physiol"},{"key":"2025090301501398000_34.177.250012.104","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.114"},{"key":"2025090301501398000_34.177.250012.105","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.45"},{"key":"2025090301501398000_34.177.250012.106","doi-asserted-by":"crossref","first-page":"642778","DOI":"10.3389\/fimmu.2021.642778","article-title":"Lung functioning and inflammation in a mouse model of systemic juvenile idiopathic arthritis","volume":"12","author":"Malengier-Devlies","year":"2021","journal-title":"Front Immunol"},{"key":"2025090301501398000_34.177.250012.107","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-018-2161-8"},{"key":"2025090301501398000_34.177.250012.108","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1038\/s41598-024-63013-y","article-title":"Longitudinal changes in the volume of residual lung lobes after lobectomy for lung cancer: a retrospective cohort study","volume":"14","author":"Tu","year":"2024","journal-title":"Sci Rep"},{"key":"2025090301501398000_34.177.250012.109","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1513\/pats.200508-094DO","article-title":"Why does the lung hyperinflate?","volume":"3","author":"Ferguson","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2025090301501398000_34.177.250012.110","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.21037\/jtd-24-83","article-title":"An analysis of residual lung volume changes after segmentectomy based on three-dimensional computed tomography","volume":"16","author":"Abe","year":"2024","journal-title":"J Thorac Dis"},{"key":"2025090301501398000_34.177.250012.111","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.08.011"},{"key":"2025090301501398000_34.177.250012.112","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01105-2019"},{"key":"2025090301501398000_34.177.250012.113","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0039OC"},{"key":"2025090301501398000_34.177.250012.114","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0032TR"},{"key":"2025090301501398000_34.177.250012.115","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1038\/s41598-022-09052-9","article-title":"Lung tissue biomechanics imaged with synchrotron phase contrast microtomography in live rats","volume":"12","author":"Cercos-Pita","year":"2022","journal-title":"Sci Rep"},{"key":"2025090301501398000_34.177.250012.116","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.3390\/ijms22126443","article-title":"Pulmonary stretch and lung mechanotransduction: implications for progression in the fibrotic lung","volume":"22","author":"Marchioni","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025090301501398000_34.177.250012.117","doi-asserted-by":"crossref","first-page":"109262","DOI":"10.1016\/j.isci.2024.109262","article-title":"Multiphase micro-computed tomography reconstructions provide dynamic respiratory function in a mouse lung fibrosis model","volume":"27","author":"Pennati","year":"2024","journal-title":"iScience"},{"key":"2025090301501398000_34.177.250012.118","doi-asserted-by":"crossref","first-page":"e172058","DOI":"10.1172\/JCI172058","article-title":"Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis","volume":"133","author":"May","year":"2023","journal-title":"J Clin Invest"},{"key":"2025090301501398000_34.177.250012.119","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3390\/diagnostics10090636","article-title":"From mouse to man and back: closing the correlation gap between imaging and histopathology for lung diseases","volume":"10","author":"Tielemans","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2025090301501398000_34.177.250012.120","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2022-0431TR"},{"key":"2025090301501398000_34.177.250012.121","doi-asserted-by":"crossref","first-page":"1338846","DOI":"10.3389\/fmed.2024.1338846","article-title":"In vivo low-dose phase-contrast CT for quantification of functional and anatomical alterations in lungs of an experimental allergic airway disease mouse model","volume":"11","author":"Dullin","year":"2024","journal-title":"Front Med"},{"key":"2025090301501398000_34.177.250012.122","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s42005-021-00760-8","article-title":"Phase-contrast X-ray tomography resolves the terminal bronchioles in free-breathing mice","volume":"4","author":"Shaker","year":"2021","journal-title":"Commun Phys"},{"key":"2025090301501398000_34.177.250012.123","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01317-x"},{"key":"2025090301501398000_34.177.250012.124","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1515\/mr-2023-0046","article-title":"Imaging and spatial omics of kidney injury: significance, challenges, advances and perspectives","volume":"3","author":"Li","year":"2023","journal-title":"Med Rev (2021)"},{"key":"2025090301501398000_34.177.250012.125","doi-asserted-by":"crossref","first-page":"e60408","DOI":"10.7554\/eLife.60408","article-title":"3D virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast X-ray tomography","volume":"9","author":"Eckermann","year":"2020","journal-title":"eLife"},{"key":"2025090301501398000_34.177.250012.126","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0071-2018"},{"key":"2025090301501398000_34.177.250012.127","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12931-023-02595-z","article-title":"Animal models of acute exacerbation of pulmonary fibrosis","volume":"24","author":"Ye","year":"2023","journal-title":"Respir Res"},{"key":"2025090301501398000_34.177.250012.128","doi-asserted-by":"crossref","first-page":"e230318","DOI":"10.1148\/radiol.230318","article-title":"Regional pulmonary morphology and function: photon-counting CT assessment","volume":"308","author":"Scharm","year":"2023","journal-title":"Radiology"},{"key":"2025090301501398000_34.177.250012.129","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118799119"},{"key":"2025090301501398000_34.177.250012.130","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1983"},{"key":"2025090301501398000_34.177.250012.131","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01819-2"},{"key":"2025090301501398000_34.177.250012.132","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/acs.jproteome.9b00838","article-title":"Proteomics analysis revealed the importance of inflammation-mediated downstream pathways and the protective role of curcumin in bleomycin-induced pulmonary fibrosis in C57BL\/6 mice","volume":"19","author":"Gouda","year":"2020","journal-title":"J Proteome Res"},{"key":"2025090301501398000_34.177.250012.133","doi-asserted-by":"crossref","first-page":"4759040","DOI":"10.1155\/2016\/4759040","article-title":"Comparative study of circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as disease markers of idiopathic pulmonary fibrosis","volume":"2016","author":"Hamai","year":"2016","journal-title":"Dis Markers"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0012-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T08:50:41Z","timestamp":1756889441000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0012-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":133,"journal-issue":{"issue":"177","published-online":{"date-parts":[[2025,9,3]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1183\/16000617.0012-2025"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0012-2025","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}